Citation Impact
Citing Papers
2017 Standout
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
2011
Reversible Paraneoplastic Encephalomyelitis Associated with a Benign Ovarian Teratoma
1999
Multidrug Resistance-Associated Proteins: Expression and Function in the Central Nervous System
2006
Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes
2012 Standout
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
2009 Standout
Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study
2013 Standout
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
2009
JAK Inhibition with Ruxolitinib versus Best Available Therapy for Myelofibrosis
2012 Standout
Update on neurological paraneoplastic syndromes
2015
Antifibrotic action of Cu/Zn SOD is mediated by TGF-β1 repression and phenotypic reversion of myofibroblasts
2001
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Structure and function of the blood–brain barrier
2009 Standout
A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle
2002
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Topical superoxide dismutase reduces post‐irradiation breast cancer fibrosis
2004
Anti-Hu-associated paraneoplastic encephalomyelitis: analysis of 200 patients
2001
Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma
2009
Recommended diagnostic criteria for paraneoplastic neurological syndromes
2004 Standout
SWI/SNF nucleosome remodellers and cancer
2011 Standout
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
2008 Standout
The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway
2004
Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy
2002
Cancer immunotherapy via dendritic cells
2012 Standout
Neuroimmunology of the paraneoplastic neurological degenerations
2004
Paraneoplastic neurological syndromes: diagnosis and treatment
2008
AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location
2009
Air pollution: mechanisms of neuroinflammation and CNS disease
2009 Standout
TGF-β1 and radiation fibrosis: a master switch and a specific therapeutic target?
2000
Paraneoplastic Neurologic Syndromes: Pathogenesis and Physiopathology
1999
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Paraneoplastic anti– N ‐methyl‐ D ‐aspartate receptor encephalitis associated with ovarian teratoma
2007 Standout
Cellular and Synaptic Mechanisms of Anti-NMDA Receptor Encephalitis
2010 Standout
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Microparticles and their emerging role in cancer multidrug resistance
2011
Potassium channel antibody‐associated encephalopathy: a potentially immunotherapy‐responsive form of limbic encephalitis
2004 Standout
Autoimmune paraneoplastic syndromes associated to lung cancer: A systematic review of the literature: Part 5: Neurological auto-antibodies, discussion, flow chart, conclusions
2017
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia
2010 Standout
Osteoclast differentiation and activation
2003 StandoutNature
Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series
2010 Standout
TGF-β and fibrosis in different organs — molecular pathway imprints
2009 Standout
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study
2013 Standout
Diagnosis, pathogenesis and treatment of the myeloproliferative disorders essential thrombocythemia, polycythemia vera and essential megakaryocytic granulocytic metaplasia and myelofibrosis
1999
Neuronal autoantigens—pathogenesis, associated disorders and antibody testing
2012
N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes
2010 Standout
Anti–N‐methyl‐D‐aspartate receptor (NMDAR) encephalitis in children and adolescents
2009 Standout
Neuroblastoma
2007 Standout
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
2013 Standout
Treatment-responsive limbic encephalitis identified by neuropil antibodies: MRI and PET correlates
2005
Classification, Functions, and Clinical Relevance of Extracellular Vesicles
2012 Standout
The Ki-67 protein: From the known and the unknown
2000 Standout
Platelet Density Distribution in Essential Thrombocythemia
2010 StandoutNobel
Current therapies for paraneoplastic neurologic syndromes
2003
Toxicity antagonists in head and neck cancer
1998
Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis
2012
Current Management for Late Normal Tissue Injury: Radiation-Induced Fibrosis and Necrosis
2007
Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis
2010 Standout
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
2010 Standout
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
2005 StandoutNature
Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration
2001
Antibodies and neuronal autoimmune disorders of the CNS
2009
Paraneoplastic syndromes of the CNS
2008
No significant predictive value of c- erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancer
1998
Head and Neck Cancer
2001 Standout
Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients
2000 Standout
Paraneoplastic disorders of the central and peripheral nervous systems
2013
Incidence and Prognostic Significance of Complete Axillary Downstaging After Primary Chemotherapy in Breast Cancer Patients With T1 to T3 Tumors and Cytologically Proven Axillary Metastatic Lymph Nodes
2002
Superoxide Dismutases: Role in Redox Signaling, Vascular Function, and Diseases
2011 Standout
Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis
2000
Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
2017
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Neuronal surface antigen antibodies in limbic encephalitis
2008
Antibody-Mediated Encephalitis
2018 Standout
Paraneoplastic neurological syndromes
2013
Transforming growth factor-β: pleiotropic role in the regulation of hematopoiesis
2000
Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients
2003
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
Early pathologic findings and long-term improvement in anti-Ma2–associated encephalitis
2006
Enterotoxigenic Escherichia coli in Developing Countries: Epidemiology, Microbiology, Clinical Features, Treatment, and Prevention
2005 Standout
Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies)
2004
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO
2003
ABCC Drug Efflux Pumps and Organic Anion Uptake Transporters in Human Gliomas and the Blood-Tumor Barrier
2005
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Opsoclonus-Ataxia Caused by Childhood Neuroblastoma: Developmental and Neurologic Sequelae
2002
Works of B Benyahia being referenced
Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndrome
2002
Transforming growth factor‐β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis
1994
Breast cancer proliferation measured on cytological samples: a study by flow cytometry of S-phase fractions and BrdU incorporation
1991
Cell-mediated autoimmunity in paraneoplastic neurological syndromes with anti-Hu antibodies
1999
Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis
2002
Protein kinase C autoimmunity in paraneoplastic cerebellar degeneration and non-small-cell lung cancer
2006
T cell response to Hu-D peptides in patients with anti-Hu syndrome
2005
Multidrug Resistance-Associated Protein MRP1 Expression in Human Gliomas: Chemosensitization to Vincristine and Etoposide by Indomethacin in Human Glioma Cell Lines Overexpressing MRP1
2004
Association of herpes simplex virus encephalitis and paraneoplastic encephalitis - a clinico-pathological study.
2000
The pathophysiology of paraneoplastic neurological syndromes.
1998
Effects of superoxide dismutase topical treatment on human skin radiofibrosis: a pathological study
1996